** = Publikationen gelistet in SCI/SSCI/Pubmed
** Benda, MA; Ulmer, H; Weger, R; Reimann, P; Lang, TRS; Pichler, P; Winder, T; Hartmann, B; Strassl, I; Krauth, MT; Agis, H; Sormann, S; Podar, K; Willenbacher, W; Willenbacher, E
Attrition Rates in Multiple Myeloma Treatment under Real World Conditions-An Analysis from the Austrian Myeloma Registry (AMR)
CANCERS. 2023; 15(3): 962
Doi: 10.3390/cancers15030962
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ludwig, H; Melchardt, T; Sormann, S; Zojer, N; Andel, J; Hartmann, BL; Tinchon, C; Gunsilius, E; Podar, K; Egle, A; Willenbacher, W; Woll, E; Schreder, M; Ruckser, R; Bozic, B; Krauth, MT; Petzer, A; Schmitt, CA; Machherndl-Spandl, S; Agis, H; Fillitz, M; Wang, SY; Knop, S; Kainz, S; Paiva, B; Greil, R
Randomized Comparison between Krd and Ktd Induction, Followed By K Maintenance or Control in Transplant NonEligible Patients with NDMM: Efficacy and Qol Data (AGMT-MM02 Trial)
BLOOD. 2022; 140: 10185-10188.
Doi: 10.1182/blood-2022-162336
Web of Science
FullText
FullText_MUG
** Willenbacher, E; Pichler, P; Strassl, I; Krauth, M; Agis, H; Sormann, S; Hartmann, B; Podar, K; Weger, R; Willenbacher, W
TRIATLON - triple class exposed/refractory multipLe myeloma patients: a real world analysis (RWA) from the Austrian Myeloma Registry (AMR)
CL LYMPH MYELOM LEUK. 2022; 22: S193-S194.
Web of Science
** Willenbacher, W; Pichler, P; Strassl, I; Krauth, MT; Agis, H; Sormann, S; Hartmann, BL; Podar, K; Weger, R; Willenbacher, E
Ninreal - a Real World (RW) Comparison of Ixazomib Triplets and IMiD Duplets, in Relapsed and Refractory Multiple Myeloma (RRMM) from the Austrian Myeloma Registry (AMR)
BLOOD. 2022; 140: 13194-13195.
Doi: 10.1182/blood-2022-165366
Web of Science
FullText
FullText_MUG
** Buxhofer-Ausch, V; Wolf, D; Sormann, S; Forjan, E; Schimetta, W; Gisslinger, B; Heibl, S; Krauth, MT; Thiele, J; Ruckser, R; Gisslinger, H
Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia.
EUR J HAEMATOL. 2021; 106(1): 58-63.
Doi: 10.1111/ejh.13516
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sormann, S; Pasteiner, W; Kahangire, DA; Greinix, H
Outcomes of relapsed/refractory multiple myeloma patients receiving carfilzomib-based therapy in routine practice; results of a single-centre Austrian registry.
ONCOL RES TREAT. 2020; 43(SUPPL 4):115-115.
[Poster]
Web of Science
** Wallner, E; Weger, R; Agis, H; Hartmann, B; Sormann, S; Krauth, M; Willenbacher, E; Strassl, I; Bauer, F; Willenbacher, W
Real life use and outcomes of pomalidomide based anti-myeloma therapies - an analysis from the Austrian Myeloma Registry (AMR).
ONCOL RES TREAT. Abstractband für die Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 2020; 43(SUPPL 4):113-113.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 9-11, 2020; Basel, SWITZERLAND.
[Poster]
Web of Science
** Weger, R; Willenbacher, E; Agis, H; Krauth, M; Sormann, S; Bauer, F; Strassl, I; Willenbacher, W
MAINTenance treatment post-ASCT of Myeloma patients documented IN the Austrian Myeloma registry - The MAINTAIN-project.
ONCOL RES TREAT. Abstractband für die Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 2020; 43(SUPPL 4):112-113.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 9-11, 2020; Basel, SWITZERLAND.
[Poster]
Web of Science
** Willenbacher, E; Agis, H; Krauth, M; Sormann, S; Weger, R; Bauer, F; Hartmann, B; Willenbacher, W
Exploring the multiple myeloma maintenance treatment landscape in Austria.
ONCOL RES TREAT. Abstractband für die Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 2020; 43(SUPPL 4):113-113.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 9-11, 2020; Basel, SWITZERLAND.
[Poster]
Web of Science
** Willenbacher, E; Weger, R; Bittrich, M; Einsele, H; Sormann, S; Bauer, F; Willenbacher, W
ALPINA: Real World Analysis of 1st line RVd treatment in Transplant Eligible & Transplant-non-Eligible MM patients with a focus on tolerability and efficacy
CL LYMPH MYELOM LEUK. Abstract Book 17th International Myeloma Workshop. 2019; 19(10):E220-E220.-17th International Myeloma Workshop; SEP 12-15, 2019; Boston, USA.
Doi: 10.1016/j.clml.2019.09.366
[Poster]
Web of Science
FullText
FullText_MUG
** Buxhofer-Ausch, V; Steurer, M; Sormann, S; Schloegl, E; Schimetta, W; Gisslinger, B; Schalling, M; Krauth, MT; Thiele, J; Ruckser, R; Gastl, G; Gisslinger, H
Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia.
EUR J HAEMATOL. 2018; 74(9):
Doi: 10.1111/ejh.13070
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sormann, S; Greinix, H
Role of TPO agonists in the chronic immune thrombocytopenia treatment algorithm - a single-center registry analysis
ONCOL RES TREAT. 2018; 41: 105-106.
[Poster]
Web of Science
** Buxhofer-Ausch, V; Steurer, M; Sormann, S; Schloegl, E; Schimetta, W; Gisslinger, B; Ruckser, R; Gastl, G; Gisslinger, H
Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia.
EUR J HAEMATOL. 2016; 97(6): 511-516.
Doi: 10.1111/ejh.12759
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Buxhofer-Ausch, V; Steurer, M; Sormann, S; Schloegel, E; Schimetta, W; Gisslinger, B; Ruckser, R; Schalling, M; Gastl, GA; Gisslinger, H
Influence of Platelet and White Blood Cell Counts until Major Thrombosis: Analysis from a Patient Registry in Essential Thrombocythemia
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
[Poster]
Web of Science
** Buxhofer-Ausch, V; Steurer, M; Sormann, S; Schloegl, E; Kralovics, R; Gisslinger, H
Leukocyte Count Defines Patients on Risk for Thrombotic Complications with Well Controlled Essential Thrombocythemia-Data from a Patient- Registry
BLOOD. 2014; 124(21):
Web of Science